Is ABUS or JBIO more profitable?

ABUS runs the higher net margin — ABUS at 84.23% versus JBIO at 0.00%.

How have ABUS and JBIO total returns compared?

Over the past 5 years, ABUS delivered 2.19% and JBIO delivered -52.65% annualized total return. Past performance doesn't predict future results.

Arbutus Biopharma Corp (ABUS) vs Jade Biosciences, Inc. (JBIO)

A side-by-side comparison of Arbutus Biopharma Corp and Jade Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ABUS

Arbutus Biopharma Corp

$891M

$4.51HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT

JBIO

Jade Biosciences, Inc.

$803M

$13.19HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT

Total return — ABUS vs JBIO

growth of $100 · dividends reinvested · last 5y

ABUS +38.6% (+6.7%/yr)JBIO -97.8% (-53.5%/yr)ABUS compounded faster over this window

Log scale — wide-divergence pair

ABUS JBIO

ABUS vs JBIO: by the numbers

•ABUS is the larger company ($891M vs $803M market cap).
•ABUS is profitable (84.23% net margin) while JBIO runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	ABUS	JBIO
P/E ratio	5.78	N/A
Forward P/E	6.09	N/A
P/S ratio	4.90	N/A
P/B ratio	3.44	1.82
EV / EBITDA	5.94	N/A

Profitability

Metric	ABUS	JBIO
Gross margin	99.98%	0.00%
Operating margin	-192.08%	0.00%
Net margin	84.23%	0.00%
ROE	59.16%	-34.83%
ROIC	54.39%	-37.39%

Growth (annualized)

Metric	ABUS	JBIO
Revenue CAGR (5Y)	85.17%	N/A
Total return CAGR (5Y)	2.19%	-52.65%

Frequently asked

Is ABUS or JBIO more profitable?: ABUS runs the higher net margin — ABUS at 84.23% versus JBIO at 0.00%.
How have ABUS and JBIO total returns compared?: Over the past 5 years, ABUS delivered 2.19% and JBIO delivered -52.65% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABUS analysis Full JBIO analysis Interactive comparison tool

Dig into the metrics

Arbutus Biopharma P/E ratio Arbutus Biopharma ROE Jade Biosciences ROE Arbutus Biopharma operating margin Jade Biosciences operating margin Arbutus Biopharma revenue growth Jade Biosciences revenue growth Arbutus Biopharma free cash flow Jade Biosciences free cash flow

Arbutus Biopharma & Jade Biosciences appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.